世界的な結核薬開発パイプライン:必要性と現実
Zhenkun Ma1, Christian Lienhardt, Helen McIlleron
1Global Alliance for TB Drug Development, New York, NY 10005, USA. zhenkun.ma@tballiance.org
Lancet (London, England)
|May 22, 2010
まとめ
近年の進展にもかかわらず,結核 (TB) に対する世界的な薬物パイプラインは依然として不十分です. 新しい結核治療法を開発し,効果的に結核と闘うために,努力と資金の強化が不可欠です.
科学分野:
- 感染症 感染症は感染症です.
- ドラッグ開発 ドラッグ開発
- 公衆衛生は公衆衛生である.
背景:
- 現在の結核 (TB) 薬は,固有の耐性および新興の耐性菌株による課題に直面しています.
- 進歩にもかかわらず,結核治療薬の世界的なパイプラインは,治療需要を満たすには不十分です.
研究 の 目的:
- 現在の結核薬パイプラインの不十分さを強調する.
- 結核治療薬の開発における主要な課題と改善すべき分野を特定する.
主な方法:
- 結核化合物の最近の臨床開発パイプラインのレビュー.
- 新しい抗結核薬剤の開発における課題の分析.
主要な成果:
- 過去10年間で10の化合物が臨床開発に入っており,そのうち6つはTBに特化したものです.
- 薬剤開発が不十分であり,パイプラインのギャップがあるため,重要な満たされていない需要が残っています.
結論:
- 持続的な取り組み,資金調達の増加,共同行動は,結核薬パイプラインを強化するために不可欠です.
- 新薬の組み合わせ,試験設計,小児研究,規制ガイドラインの課題に取り組むことは,2050年までに結核の撲滅に不可欠です.
関連する概念動画
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:

